Leflunomide (Arava) in early rheumatoid arthritis
Objective. To assess efficacy and safety of leflunomide in the treatment of early rheumatoid arthritis (RA). Material and methods. 30 pts with RA aged 18 to 67 years were examined. 17 pts with disease duration less than 6 months (mean 3,6±2,6 months) were included in group 1 and 13 pts with disease...
Main Authors: | R V Balabanova, D E Karateev, R YKashevarov, E L Luchihina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2005-10-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/322 |
Similar Items
-
Leflunomide monotherapy in patients with early rheumatoid arthritis: Results of the Russian national Arava mono study
by: Rimma Mikhailovna Balabanova, et al.
Published: (2012-06-01) -
LEFLUNOMIDE IN EARLY RHEUMATOID ARTHRITIS: INCLUSION IN THE TREATMENT STRATEGY AND PROSPECTS
by: D. E. Karateev, et al.
Published: (2017-12-01) -
Efficiency and safety of leflunomide in rheumatoid arthritis: Results of a Russian observational multicenter of trial
by: R. M. Balabanova, et al.
Published: (2015-06-01) -
LEFLUNOMIDE IN RHEUMATOID ARTHRITIS: URGENT MATTERS OF PRACTICAL USE
by: Yuri Aleksandrovich Olyunin
Published: (2009-09-01) -
Changes in inflammatory activity of rheumatoid arthritis at early stages of basic therapy with leflunomide
by: R M Balabanova, et al.
Published: (2004-05-01)